Are you living with Chronic Obstructive Pulmonary Disease (COPD) or know someone who is?
M3 Wake Research is now enrolling participants for COPD clinical studies aimed at exploring new and innovative treatments. By joining our research studies, you can access potential, cutting-edge therapies, receive high-quality medical care, and contribute to the future of COPD treatment.
As one of the nation’s leading clinical research networks, M3 Wake Research is committed to advancing medical knowledge and improving patient outcomes. Complete the application form to learn how you can get involved today.
Understanding Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by chronic inflammation and airflow limitation in the lungs. It is the third leading cause of death worldwide, affecting over 300 million people globally. COPD is often caused by long-term exposure to lung irritants such as cigarette smoke, air pollution, and dust. Genetic factors, such as alpha-1 antitrypsin deficiency, can also contribute to the development of this condition.
COPD is a complex disease involving multiple pathophysiological mechanisms, including chronic bronchitis, emphysema, and airway disease:
- Chronic bronchitis is marked by persistent inflammation and mucus production in the airways.
- Emphysema involves the destruction of lung tissue and the formation of air pockets.
- Airway disease is characterized by chronic inflammation and narrowing of the airways, making it difficult to breathe.
COPD patients often experience symptoms such as shortness of breath, wheezing, and coughing. The disease can also lead to severe exacerbations, which are acute episodes of worsening symptoms that can result in hospitalization, irreversible lung damage, or even death. Understanding the nature of COPD is crucial for managing its symptoms and improving the quality of life for those affected.
Why Participate in COPD Studies at M3 Wake Research?
Joining a clinical study with M3 Wake Research means you will be at the forefront of medical innovation, gaining access to potential treatments that are not yet available to the general public. Clinical trials often have a primary endpoint, such as the annualized rate of moderate or severe exacerbations, to measure the effectiveness of treatments. By participating, you will receive:
- Access to Potential New Treatments: You may receive investigational therapies designed to improve lung function and manage COPD symptoms before they are widely available.
- High-Quality Medical Care: Our team of healthcare professionals provides personalized care and closely monitors your health throughout the study.
- Potential Compensation for Time and Travel: Participants are often compensated for their time and travel expenses, helping to minimize any financial impact.
- Contribute to Medical Science: Your participation helps us develop new treatments and improve COPD management for patients worldwide.
The Importance of Clinical Trials for COPD Patients
Clinical trials play a crucial role in the development of new treatments for COPD patients. These trials provide a safe and controlled environment for researchers to test potential new medications, devices, and therapies, and to evaluate their safety and efficacy.
Clinical trials for COPD patients are designed to address various aspects of the disease, including disease progression, COPD exacerbations, and quality of life. These trials often involve the use of biologics, which are medications that target specific molecules involved in the disease process.
One of the key benefits of clinical trials for COPD patients is the opportunity to access new and innovative treatments that may not be available otherwise. Clinical trials also provide patients with the opportunity to contribute to the advancement of medical knowledge and to help others with the same disease.
In addition, clinical trials for COPD patients often involve a multidisciplinary team of healthcare professionals, including pulmonologists, critical care specialists, and respiratory therapists. This team approach ensures that patients receive comprehensive care and support throughout the trial.
Overall, clinical trials are essential for the development of new treatments for COPD patients and for improving our understanding of this complex disease. By participating in clinical trials, patients can play an active role in shaping the future of COPD treatment and improving the lives of others with the disease.
What to Expect When Enrolling in a COPD Study
If you choose to apply to participate in a COPD study with M3 Wake Research, you can expect a comprehensive and supportive process designed to ensure your safety and comfort:
- Pre-Screening Process: Our team will conduct a pre-screening evaluation, either over the phone or online, to determine if you qualify for a study.
- Initial Evaluation: Qualified participants undergo a thorough medical assessment, including lung function tests, blood tests, and other necessary evaluations to confirm eligibility.
- Study Enrollment: Once eligible, you will be enrolled in the study and provided with detailed information about the treatment protocol, schedule, and what to expect during each visit.
- Ongoing Monitoring: Our healthcare team will provide continuous support and monitor your progress throughout the study to ensure safety and well-being.
Current COPD Clinical Trials Available at M3 Wake Research
M3 Wake Research is currently enrolling participants for several COPD studies aimed at testing innovative therapies and treatment approaches. Our studies include:
- Inhaler Therapy Trials: Testing new inhaler devices that may improve lung function and reduce COPD symptoms. These trials may include Phase III studies to compare new inhalers with existing treatments.
- Anti-Inflammatory Medication Studies: Evaluating the safety and effectiveness of new medications designed to reduce lung inflammation. These studies often involve chronic dosing regimens to evaluate long-term safety and efficacy.
- Pulmonary Rehabilitation Programs: Combining medication with rehabilitation programs that focus on improving physical fitness, respiratory health, and overall quality of life for COPD patients.
Use our Find a Trial Tool for a complete list of our ongoing studies and eligibility criteria.
Eligibility Criteria for COPD Patients in Studies
M3 Wake Research follows specific criteria to determine eligibility for COPD studies, ensuring participant safety and the effectiveness of our trials. General requirements may include:
- Confirmed COPD Diagnosis: Participants must have a confirmed diagnosis of COPD, including conditions like chronic bronchitis or emphysema.
- Age Range: Most studies require participants to be between 40 and 80 years old, though age limits can vary by trial.
- Smoking Status: We welcome non-smokers and former smokers who have quit for a specified period, typically six months or longer.
- Stable Health: Participants should have a stable condition without recent exacerbations or hospitalizations for COPD.
Our team will work with you to determine if you meet the requirements for one of our studies.
How to Enroll in a COPD Study at M3 Wake Research
If you or a loved one are interested in participating in one of our currently-enrolling COPD studies, follow these steps to get started:
- Contact Us: Complete the study survey or reach out via our contact form. Our team will guide you through the initial steps and answer any questions you may have.
- Complete Pre-Screening: Our specialists will conduct a pre-screening interview to determine your eligibility for a COPD study. Research in COPD may also help to reduce the risk of developing lung cancer by targeting inflammation.
- Schedule an Evaluation: If you qualify, we will schedule a comprehensive evaluation at one of our convenient locations. Advancements in COPD research contribute to the treatment of other respiratory diseases such as asthma.
- Begin Your Participation: Upon successful enrollment, you will receive a detailed study schedule and information about your visits and treatment protocol.
M3 Wake Research Locations Currently Enrolling COPD Studies
Whether you are a local patient or are interested in traveling to find advanced treatments for a COPD diagnosis, M3 Wake Research has clinical research sites across the United States. Locations that are currently enrolling for our upcoming COPD clinical trial include:
M3 Wake Research Charleston
Located in the beautiful Lowcountry, M3 Wake Research Charleston offers our clinical trials for those located in and around the Southeast. Consider applying to our COPD trial in Charleston, South Carolina.
M3 Wake Research Chattanooga
Serving communities in Tennessee and North Georgia, M3 Wake Research Chattanooga is set amidst the mountains of Southern Appalachia. If you’re located near these areas, this is a great option to contribute to the future of COPD research.
M3 Wake Research Lake City
Situated in Northern Florida, M3 Wake Research Lake City is an ideal location for participants in the South Georgia, South Alabama, and North-Central Florida areas who want to participate in our COPD trials.
M3 Wake Research Los Alamitos
Located near popular Long Beach, M3 Wake Research Los Alamitos offers an idyllic location for participants in Southern California. If you’re near the Southern California area, consider applying to our currently enrolling COPD studies in Los Alamitos.
M3 Wake Research Newport Beach
One of the most desirable areas in Southern California, M3 Wake Research Newport Beach offers a beautiful setting to help researchers test potential new devices and treatments that may contribute to advanced options for this chronic condition.
M3 Wake Research Raleigh
Situated in central North Carolina, M3 Wake Research Raleigh is our headquarters and offers residents of the North Carolina and Southern Virginia areas the opportunity to apply to our COPD studies.
M3 Wake Research San Diego – Convoy
Located in sunny Southern California, M3 Wake Research San Diego – Convoy is ideally situated in San Diego, California. Enjoy the beautiful weather San Diego is known for while participating in our COPD clinical trial.
M3 Wake Research Tucson
M3 Wake Research Tucson is set amidst the beautiful desert backdrop, offering the opportunity for residents in the Southern Arizona and Eastern California areas to participate in our openly-enrolling COPD studies.
How COPD Research at M3 Wake Research Benefits Future Treatments and Disease Progression
COPD research is critical to developing new and effective treatments that can improve the lives of millions. Each study participant plays an essential role in helping researchers collect valuable data, leading to breakthroughs, such as:
- New Inhaler Technologies: We test inhaler devices designed to deliver medication more efficiently, improving breathing for COPD patients.
- Advanced Anti-Inflammatory Drugs: Studies focus on developing medications that target lung inflammation and improve respiratory function.
- Innovative Rehabilitation Programs: Research is exploring ways to enhance pulmonary rehabilitation programs, combining medication with physical activity and education for better outcomes.
By participating in our clinical studies, you contribute to these potential advancements, helping shape the future of COPD care.
COPD Clinical Trial FAQs
How do I know if I qualify for a COPD study at M3 Wake Research?
Complete the study survey to see if you qualify for our currently-enrolling clinical trials. If you qualify, our team will guide you through the pre-screening process to determine your eligibility. Learn more about the clinical trial process here.
What benefits do participants receive?
Participants gain access to cutting-edge treatments, receive high-quality medical care, and are compensated for their time and travel expenses.
Are COPD studies safe?
Yes, our studies follow strict safety protocols and are monitored by healthcare professionals to ensure participant safety at all stages.
Is there any cost to participate?
No, there is no cost to participate in our studies. In fact, we often provide compensation for time and travel expenses.
How long do the COPD studies last?
The duration of studies varies depending on the type of therapy being tested but typically ranges from several months to a year.
What if I experience side effects during the study?
M3 Wake Research’s team of healthcare professionals closely monitors participants throughout the study and provides immediate care if any side effects occur.
Contribute to the Future of COPD in our Research Studies
Participating in COPD studies at M3 Wake Research offers you a unique opportunity to access the latest potential treatments and therapies while making a meaningful contribution to the future of medical research. Whether you are seeking potential new and advanced treatment options or want to help advance COPD care, M3 Wake Research is here to support you every step of the way.
Complete our survey today to learn more about our COPD studies and to see if you qualify to enroll.
Who We Are: M3 Wake Research
M3 Wake Research is a premier clinical trial site network with 14 locations across the United States. Professionals from divisions of pulmonary and critical care medicine are actively involved in our clinical trials, particularly those evaluating treatment options for severe respiratory conditions like COPD. We collaborate with leading pharmaceutical companies, biotech firms, and medical device manufacturers to bring new treatments to market.
Our mission is to provide safe, high-quality, and cutting-edge clinical trials that help improve patient care and advance medical science. For individuals living with COPD, our studies offer an opportunity to receive the latest potential treatments and therapies while contributing to essential medical research.